Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Dare Bioscience, Inc. (DARE) had Free Cash Flow per Share of $-0.38 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.15M |
|
$-3.00M |
|
$0.24M |
|
$-0.09M |
|
$3.15M |
|
$-3.00M |
|
$-0.00M |
|
$-3.00M |
|
$-3.00M |
|
$-3.00M |
|
$-3.00M |
|
$-3.00M |
|
$-3.00M |
|
$-3.00M |
|
$-2.44M |
|
14.52M |
|
14.52M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$21.66M |
|
$1.45M |
|
$6.17M |
|
$27.83M |
|
$21.12M |
|
-- |
|
$5.97M |
|
$27.09M |
|
$0.73M |
|
$0.73M |
|
$0.73M |
|
14.56M |
|
| Cash Flow Statement Financials | |
$-5.52M |
|
$0.00M |
|
$-0.72M |
|
$25.01M |
|
$18.82M |
|
$-6.19M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
-58.95% |
|
-1967.07% |
|
-1967.07% |
|
-- |
|
-1967.72% |
|
-1967.72% |
|
$-5.52M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.22 |
|
406.01 |
|
-408.82% |
|
-408.45% |
|
-10.78% |
|
-408.45% |
|
$0.05 |
|
|
Free Cash Flow per Share |
$-0.38 |
$-0.38 |
|